cosmos2024
@genders2q98
BioAge Labs is expanding its pipeline through fresh collaborations and development projects, working on next-gen APJ agonists and NLRP3 inhibitors, and teaming up with Lilly to tackle aging-related targets.
0 reply
0 recast
0 reaction